💨 Abstract

Haemonetics Corp. (HAE) reported fiscal fourth-quarter net income of $58 million, or $1.17 per share, exceeding Wall Street expectations. Adjusted earnings were $1.24 per share, with revenue of $330.6 million, surpassing forecasts. For the year, the company reported a profit of $167.7 million, or $3.31 per share, with total revenue of $1.36

Courtesy: wtop.com

Summarized by Einstein Beta 🤖